Us Bancorp \De\ Abb Vie Inc. Put Options Transaction History

Us Bancorp \De\

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 03, 2023	BUY	$133.59 - $154.65 $667 - $773	5 New	5 $0
Q1 2023 May 09, 2023	BUY	$144.61 - $166.54 $723 - $832	5 New	5 $0
Q2 2021 Aug 05, 2021	SELL	$105.21 - $117.21 $1,472 - $1,640	-14 Reduced 73.68%	5 $0
Q4 2020 Feb 04, 2021	SELL	$80.49 - $108.67 $17,546 - $23,690	-218 Reduced 91.98%	19 $1,000
Q3 2020 Nov 10, 2020	BUY	$85.91 - $100.83 $429 - $504	5 Added 2.16%	237 $81,000
Q2 2020 Aug 07, 2020	BUY	$73.37 - $98.18 $2,201 - $2,945	30 Added 14.85%	232 $88,000
Q4 2019 Feb 04, 2020	BUY	$72.13 - $90.25 $14,570 - $18,230	202 New	202 $38,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.